SCHEMBL10037124

SCHEMBL10037124

Cc1cc(Br)ccc1NC(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.45
ALDH1A1 P00352 4/20 0.44
NPSR1 Q6W5P4 1/20 0.44
LMNA P02545 2/20 0.42
HTT P42858 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
HPGD P15428 1/20 0.41
MAPT P10636 4/20 0.41
MAPK1 P28482 1/20 0.40
POLB P06746 1/20 0.40
DHODH Q02127 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
IDO1 P14902 1/20 0.39
GAA P10253 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19382446 0.86 SIGMAR1 (0.44) SIGMAR1ALDH1A1NPSR1LMNAHTT
SCHEMBL15854539 0.83 LMNA (0.42) SIGMAR1ALDH1A1NPSR1LMNAHTT
SCHEMBL10407959 0.80 SIGMAR1 (0.40) SIGMAR1ALDH1A1NPSR1LMNAHTT
SCHEMBL17018034 0.80 MAPT (0.43) SIGMAR1ALDH1A1NPSR1LMNAHTT
SCHEMBL10037099 0.78 RAPGEF4 (0.52) ALDH1A1LMNAHTTSMN1; SMN2MEN1
SCHEMBL29673248 0.78 AAK1 (0.43) ALDH1A1LMNAHTTSMN1; SMN2MEN1
SCHEMBL9102892 0.78 AAK1 (0.43) ALDH1A1LMNAHTTSMN1; SMN2MEN1
SCHEMBL10408259 0.78 GABRA1 (0.42) ALDH1A1LMNAHTTSMN1; SMN2MEN1
SCHEMBL741149 0.78 KDM4E (0.46) ALDH1A1LMNAHTTSMN1; SMN2HPGD
SCHEMBL4611466 0.76 SIGMAR1 (0.49) SIGMAR1ALDH1A1NPSR1HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022070-A1 Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use EMORY UNIVERSITY (US) 2012-01-26 US disclosed
US-4925984-A REACTION WITH BROMINE IN SOLUTION ETHYL CORPORATION (US) 1990-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022070-A1 Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use HSP90AB1, HSP90AA1, HSP90AB2P SIGMAR1 3928/4885ALDH1A1 2606/4885NPSR1 4378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.